Expression of prostatic factors measured by reverse transcription polymerase chain reaction in human papillomavlrus type 18 deoxyribonucleic acid immortalized prostate cell lines

Urology

Volumn 51, Issue 4, 1998, Pages 657-662

  Weijerman, Philip C ^a   Zhang, Yan ^b   Shen, Jiancheng ^b   Dubbink, Hendrikus J ^b   Romijn, Johannes C ^b   Peehl, Donna M ^b   Schröder, Fritz H ^b  

^a RIJNSTATE HOSPITAL   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; VIRUS DNA;

ARTICLE; CARCINOGENESIS; CELL IMMORTALIZATION; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE MARKER; DNA TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; RNA TRANSCRIPTION; VIRUS TRANSFORMATION; WART VIRUS;

ANTIGENS, SURFACE; CARBOXYPEPTIDASES; CELLS, CULTURED; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; MALE; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; RECEPTORS, ANDROGEN; TRANSFECTION;

EID: 0031897954     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00696-1     Document Type: Article

References (50)

1. Peehl DM: Culture of human prostatic epithelial cells, in Freshney IA (Ed): Culture of Epithelial Cells. New York, Wiley-Liss, 1992, pp 159-180.
2. Kaighn ME, Reddel RR, Lechner JF, Peehl DM, Camalier RF, Brash DE, Saffiotti U, and Harris C: Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40 early region genes. Cancer Res 49: 3050-3056, 1989.
3. Cussenot O, Berthon P, Berger R, Mowszowics I, Faille A, Hojman F, Teillac P, Le Due A, and Calvo F: Immortalization of human prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urol 143: 881-886, 1991.
4. Lee MS, Garvenko E, Yun JS, Weijerman PC, Peehl DM, Chen LS, and Rhim JS: Characterization of adult human prostate epithelial cells immortalized by polybrene-induced DNA transfection with a plasmid containing an origin defective SV40-genome. Int J Oncol 4: 821-830, 1994.
5. Bae VL, Jackson-Cook CK, Brothman AR, Maygarden SJ, and Ware JL: Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: association with decreased epidermal growth factor receptor (EGFR) expression. Int J Cancer 58: 721-729, 1994.
6. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, and Narayan P: Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro 31: 14-24, 1995.
7. McNicol PJ, and Dodd JG: High prevalence of human papillomavirus in prostate tissues. J Urol 145: 850-853, 1991.
8. Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, and Inuzuka M: Presence of ras oncogene mutations and human papillomavirus DNA in prostate carcinomas. Cancer Res 52: 5991-5996, 1992.
9. Rotola A, Monini D, Di Luca D, Savioli A, Simone R, Secchiero P, Reggiani A, and Cassai E: Presence and physical state of HPV DNA in prostate and urinary-tract tissues. Int J Cancer 52: 359-365, 1992.
10. Ibrahim GK, Gravitt PE, Dittrich KL, Ibrahim SN, Melhus O, Anderson M, and Robertson CN: Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization. J Urol 148: 1822-1826, 1992.
11. Sarkar FH, Sakr WA, Li YW, Sreepathi P, and Crissman JD: Detection of human papillomavirus (HPV) DNA in human prostatic tissues by polymerase chain reaction (PCR). Prostate 22: 171-180, 1993.
12. Tu H, Jacobs SC, Mergner WJ, and Kyprianou N: Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer. Urology 44: 726-731, 1994.
13. Moyret-Lalle C, Marcais C, Jacquemier J, Moles J-P, Daver A, Soret J-Y, Jeanteur P, Ozturk M, and Theillet C: ras, p53 and HPV status in benign and malignant prostate tumors. Int J Cancer 64: 124-129, 1995.
14. Widerhoff L, Schottenfeld D, Carey TE, Beals T, Fu G, Sakr WA, Sarkar FH, Schork A, Grossman HB, and Shaw MW: Human papillomavirus DNA in malignant and hyperplastic prostate tissue in black and white males. Prostate 28: 117-123, 1996.
15. Suzuki H, Komiya A, Aida S, Ito H, Yatani R, and Shimazaki J: Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer. Prostate 28: 318-324, 1996.
16. Terris MK, and Peehl DM: Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized. Urology 50: 150-156, 1997.
17. De Villiers E-M: Heterogeneity of the human papillomavirus group. J Virol 63: 4898-4903, 1989.
18. Arends MJ, Wyllie AH, and Bird CC: Papillomavirus and human cancer. Hum Pathol 21: 686-698, 1990.
19. Zur Hausen H, and de Villiers E-M: Human papillomaviruses. Ann Rev Microbiol 48: 427-447, 1994.
20. Sarkar FH, Miles BJ, Pleith DA, and Crissman JD: Detection of human papillomavirus in squamous neoplasm of the penis. J Urol 147: 389-392, 1992.
21. Iwasawa A, Kumamoto Y, and Fujinaga K: Detection of human papillomavirus deoxyribonucleic acid in penile carcinoma by polymerase chain reaction and in situ hybridization. J Urol 149: 59-63, 1993.
22. Cupp MR, Malek RS, Goellner JR, Smith TF, and Espy MJ: The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol 154: 1024-1029, 1995.
23. Cupp MR, Malek RS, Goellner JR, Espy MJ, and Smith TF: Detection of human papillomavirus DNA in primary squamous cell carcinoma of the male urethra. Urology 48: 551-555, 1996.
24. Anwar K, Naiki H, Nakakuki K, and Inuzuka M: High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 70: 1967-1973, 1992.
25. Noel JC, Thiry L, Verhest A, Deschepper N, Peny MO, Sattar AA, Schulman CC, and Haot J: Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses. Urology 44: 671-675, 1994.
26. Weijerman PC, König JJ, Wong ST, Niesters HGM, and Peehl DM: Lipofection-mediated immortalization of human prostate epithelial cells of normal and malignant origin using human papilloma virus type 18 DNA. Cancer Res 54: 5579-5583, 1994.
27. Peehl DM, Wong ST, and Rhim JS: Altered growth regulation of prostatic epithelial cells by human papillomavirusinduced transformation. Int J Oncol 6: 1177-1184, 1995.
28. 3. Int J Oncol 8: 41-47, 1996.
29. Peehl DM, Wong ST, and Rhim JS: Transformation-altered growth factor responses of human prostatic epithelial cells. Radiat Oncol Investig 3: 330-332, 1996.
30. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, and Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 43: 1808-1818, 1983.
31. Soule HD, Vazquez J, Long A, Alberts S, and Brennan MA: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1416, 1973.
32. Romijn JC, Erkens-Schulze S, and Schröder FH: Perspectives of the use of tissue culture methods as an alternative to human prostate cancer xenografts in nude mice, in Arnold W, Köpf-Maier P, and Micheel B (Eds): Immunodeficient Animals: Models for Cancer Research. Basel, Karger, 1996, vol 51, pp 209-213.
33. Limon J, Lundgren R, Elving P, Heim S, Kristofferson U, Mandahl N, and Mittelman F: An improved technique for short term culturing of human prostatic adenocarcinoma tissue for cytogenetic analysis. Cancer Genet Cytogenet 46:191-199, 1990.
34. Gekeler V, Beck J, Noller A, Wilisch A, Frese G, Neumann M, Handgretinger R, Ehninger G, Probst H, and Niethemmer D: Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias. Ann Hematol 69(suppl): 19-24, 1994.
35. Israeli RS, Miller WH Jr, Su SL, Powell TC, Fair WR, Samadi DS, Huryk RF, DeBlasio A, Edwards ET, Wise GJ, et al: Sensitive nested reverse transcriptase polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assay. Cancer Res 54: 6306-6310, 1994.
36. Israeli RS, Powell CT, Fair WR, and Heston WDW: Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 53: 227-230, 1993.
37. Riegman PHJ, Klaassen P, van der Korput JAGM, Romijn JC, and Trapman J: Molecular cloning and characterization of novel prostate antigen cDNAs. Biochem Biophys Res Commun 155: 181-188, 1988.
38. Romijn JC, Verkoelen CF, and Schröder FH: Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of the test conditions and assessment of hormone-stimulated growth and drug induced cytostatic and cytotoxic effects. Prostate 12: 99-110, 1988.
39. Ruizeveld de Winter JA, Trapman J, Vermey M, Mulder E, Zegers ND, and van der Kwast TH: Androgen receptor expression in human tissue: an immunohistochemical study. J Histochem Cytochem 39: 927-936, 1991.
40. Kuiper GGJM, de Ruiter PE, Trapman J, Boersma WJA, Grootegoed JA, and Brinkmann AO: Localization and hormonal stimulation of phosphorylation sites in the LNCaP-cell androgen receptor. Biochem J 291: 95-101, 1993.
41. Rhim JS, Webber MM, Bello D, Lee MS, Arnstein P, Chen LS, and Jay G: Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. Proc Natl Acad Sci USA 91: 11874-11878, 1994.
42. Dodd JG, Paraskevas M, and McNicol PJ: Detection of human papillomavirus 16 transcription in human prostate tissues. J Urol 149: 400-402, 1993.
43. Cuzick J: Human papillomavirus infection of the prostate. Cancer Surv 23: 91-95, 1995.
44. Wang MC, Valenzuela LA, Murphy GP, and Chu TM: Purification of a human prostate specific antigen. Invest Urol 17: 159-163, 1979.
45. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, and Redwine EA: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916, 1987.
46. Bangma CH, Blijenberg BG, and Schröder FH: Prostate-specific antigen in clinical use and screening for prostate cancer. Scand J Clin Lab Invest 55: 35-44, 1995.
47. van Steenbrugge GJ, Groen JW, van Dongen JW, Bolt J, van der Korput H, Trapman J, Hasenson M, and Horoszewicz J: The human prostatic carcinoma cell line LNCaP and its derivatives: an overview. Urol Res 17: 71-77, 1989.
48. Webber MM, Bello D, Kleinman HK, Wartinger DD, Williams DE, and Rhim JS: Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostate epithelial cell line. Carcinogenesis 17: 1641-1646, 1996.
49. Kawakami M, and Nakayama J: Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization. Cancer Res 57: 2321-2324, 1997.
50. Henttu P, and Vihko P: Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Cancer Res 53: 1051-1058, 1993.